Detalhe da pesquisa
1.
Transcription factor Foxo1 represses T-bet-mediated effector functions and promotes memory CD8(+) T cell differentiation.
Immunity
; 36(3): 374-87, 2012 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22425248
2.
A central role for mTOR kinase in homeostatic proliferation induced CD8+ T cell memory and tumor immunity.
Immunity
; 34(4): 541-53, 2011 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-21511183
3.
The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin.
Immunity
; 32(1): 67-78, 2010 Jan 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-20060330
4.
ß-Catenin in dendritic cells exerts opposite functions in cross-priming and maintenance of CD8+ T cells through regulation of IL-10.
Proc Natl Acad Sci U S A
; 112(9): 2823-8, 2015 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25730849
5.
Uncoupling protein 2 regulates metabolic reprogramming and fate of antigen-stimulated CD8+ T cells.
Cancer Immunol Immunother
; 65(7): 869-74, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27271549
6.
Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients.
Proc Natl Acad Sci U S A
; 109(15): 5797-802, 2012 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22454499
7.
Regulating mammalian target of rapamycin to tune vaccination-induced CD8(+) T cell responses for tumor immunity.
J Immunol
; 188(7): 3080-7, 2012 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22379028
8.
Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.
Proc Natl Acad Sci U S A
; 107(17): 7875-80, 2010 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-20385810
9.
Effects of 1-methyltryptophan stereoisomers on IDO2 enzyme activity and IDO2-mediated arrest of human T cell proliferation.
Cancer Immunol Immunother
; 61(11): 2013-20, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22527253
10.
Tc17 cells are capable of mediating immunity to vaccinia virus by acquisition of a cytotoxic phenotype.
J Immunol
; 185(4): 2089-98, 2010 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20624947
11.
CXCR6 by increasing retention of memory CD8+ T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer.
J Immunother Cancer
; 9(10)2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34607898
12.
NY-ESO-1 protein glycosylated by yeast induces enhanced immune responses.
Yeast
; 27(11): 919-31, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20672253
13.
Angiostatic activity of the antitumor cytokine interleukin-21.
Blood
; 112(13): 4940-7, 2008 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18515660
14.
The acute phase protein haptoglobin regulates host immunity.
J Leukoc Biol
; 84(1): 170-81, 2008 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-18436583
15.
Aspergillus fumigatus extract differentially regulates antigen-specific CD4+ and CD8+ T cell responses to promote host immunity.
J Leukoc Biol
; 80(3): 529-37, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16793916
16.
LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model.
Oncotarget
; 6(29): 27359-77, 2015 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26318293
17.
Direct tumor recognition by a human CD4(+) T-cell subset potently mediates tumor growth inhibition and orchestrates anti-tumor immune responses.
Sci Rep
; 5: 14896, 2015 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26447332
18.
Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cells.
Cancer Immunol Res
; 2(4): 341-50, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24764581
19.
ß-catenin mediates tumor-induced immunosuppression by inhibiting cross-priming of CD8⺠T cells.
J Leukoc Biol
; 95(1): 179-90, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24023259
20.
Prostate derived Ets transcription factor and Carcinoembryonic antigen related cell adhesion molecule 6 constitute a highly active oncogenic axis in breast cancer.
Oncotarget
; 4(4): 610-21, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23592399